 |
PDBsum entry 3i06
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
J Med Chem
53:52-60
(2010)
|
|
PubMed id:
|
|
|
|
|
| |
|
Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB.
|
|
B.T.Mott,
R.S.Ferreira,
A.Simeonov,
A.Jadhav,
K.K.Ang,
W.Leister,
M.Shen,
J.T.Silveira,
P.S.Doyle,
M.R.Arkin,
J.H.McKerrow,
J.Inglese,
C.P.Austin,
C.J.Thomas,
B.K.Shoichet,
D.J.Maloney.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Trypanosoma cruzi and Trypanosoma brucei are parasites that cause Chagas'
disease and African sleeping sickness, respectively. Both parasites rely on
essential cysteine proteases for survival: cruzain for T. cruzi and
TbCatB/rhodesain for T. brucei. A recent quantitative high-throughput screen of
cruzain identified triazine nitriles, which are known inhibitors of other
cysteine proteases, as reversible inhibitors of the enzyme. Structural
modifications detailed herein, including core scaffold modification from
triazine to purine, improved the in vitro potency against both cruzain and
rhodesain by 350-fold, while also gaining activity against T. brucei parasites.
Selected compounds were screened against a panel of human cysteine and serine
proteases to determine selectivity, and a cocrystal was obtained of our most
potent analogue bound to cruzain.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.K.Doak,
H.Wille,
S.B.Prusiner,
and
B.K.Shoichet
(2010).
Colloid formation by drugs in simulated intestinal fluid.
|
| |
J Med Chem,
53,
4259-4265.
|
 |
|
|
|
|
 |
M.B.Boxer,
A.M.Quinn,
M.Shen,
A.Jadhav,
W.Leister,
A.Simeonov,
D.S.Auld,
and
C.J.Thomas
(2010).
A highly potent and selective caspase 1 inhibitor that utilizes a key 3-cyanopropanoic acid moiety.
|
| |
ChemMedChem,
5,
730-738.
|
 |
|
|
|
|
 |
R.S.Ferreira,
A.Simeonov,
A.Jadhav,
O.Eidam,
B.T.Mott,
M.J.Keiser,
J.H.McKerrow,
D.J.Maloney,
J.J.Irwin,
and
B.K.Shoichet
(2010).
Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors.
|
| |
J Med Chem,
53,
4891-4905.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Y.T.Chen,
L.S.Brinen,
I.D.Kerr,
E.Hansell,
P.S.Doyle,
J.H.McKerrow,
and
W.R.Roush
(2010).
In vitro and in vivo studies of the trypanocidal properties of WRR-483 against Trypanosoma cruzi.
|
| |
PLoS Negl Trop Dis,
4,
0.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |